# Protagenic Therapeutics, Inc.\\new: Form 10-QT, filed Sep 10, 2025

- Company: [Protagenic Therapeutics, Inc.\\new](/companies/ptix.md) (CIK 1022899)
- Form: 10-QT
- Filed: 2025-09-10
- Accepted by EDGAR: Sep 10, 2025, 16:06 ET
- Period: 2025-06-30
- Accession: 0001641172-25-027041
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1022899/000164117225027041/form10-qt.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1022899/000164117225027041/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-04-01 to 2025-06-30 | $0 | us-gaap:Revenues |
| Research and development | 3 months, 2025-04-01 to 2025-06-30 | $394.1k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2025-04-01 to 2025-06-30 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2025-04-01 to 2025-06-30 | −$5.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-04-01 to 2025-06-30 | −$1.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-04-01 to 2025-06-30 | −$1.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-04-01 to 2025-06-30 | 3,701,226 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2025-04-01 to 2025-06-30 | −$1.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2025-06-30 | $4.1m | us-gaap:Cash |
| Current assets | at 2025-06-30 | $4.3m | us-gaap:AssetsCurrent |
| Total assets | at 2025-06-30 | $6.5m | us-gaap:Assets |
| Current liabilities | at 2025-06-30 | $10.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-06-30 | $10.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2025-06-30 | −$4.0m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1022899/000164117225027041/form10-qt.htm

Filed Sep 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-027041. Last ingested by Listed: Nov 6, 2026, 14:34 ET. No prices; not investment advice.